Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1981 1
1982 1
1983 1
1985 1
1986 3
1988 1
1989 1
1990 1
1992 1
1993 1
2005 1
2007 2
2008 4
2009 2
2010 1
2011 2
2012 5
2013 2
2014 9
2015 10
2016 3
2017 9
2018 4
2019 3
2020 8
2021 12
2022 21
2023 20
2024 10
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

138 results

Results by year

Filters applied: . Clear all
Page 1
Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis.
Payne AB, Watts JA, Mitchell PK, Dascomb K, Irving SA, Klein NP, Grannis SJ, Ong TC, Ball SW, DeSilva MB, Natarajan K, Sheffield T, Bride D, Arndorfer J, Naleway AL, Koppolu P, Fireman B, Zerbo O, Timbol J, Goddard K, Dixon BE, Fadel WF, Rogerson C, Allen KS, Rao S, Mayer D, Barron M, Reese SE, Rowley EAK, Najdowski M, Ciesla AA, Mak J, Reeves EL, Akinsete OO, McEvoy CE, Essien IJ, Tenforde MW, Fleming-Dutra KE, Link-Gelles R. Payne AB, et al. Among authors: ong tc. Lancet. 2024 Oct 19;404(10462):1547-1559. doi: 10.1016/S0140-6736(24)01738-0. Lancet. 2024. PMID: 39426837
Interim Estimates of 2024-2025 COVID-19 Vaccine Effectiveness Among Adults Aged ≥18 Years - VISION and IVY Networks, September 2024-January 2025.
Link-Gelles R, Chickery S, Webber A, Ong TC, Rowley EAK, DeSilva MB, Dascomb K, Irving SA, Klein NP, Grannis SJ, Barron MA, Reese SE, McEvoy C, Sheffield T, Naleway AL, Zerbo O, Rogerson C, Self WH, Zhu Y, Lauring AS, Martin ET, Peltan ID, Ginde AA, Mohr NM, Gibbs KW, Hager DN, Prekker ME, Mohamed A, Johnson N, Steingrub JS, Khan A, Felzer JR, Duggal A, Wilson JG, Qadir N, Mallow C, Kwon JH, Columbus C, Vaughn IA, Safdar B, Mosier JM, Harris ES, Chappell JD, Halasa N, Johnson C, Natarajan K, Lewis NM, Ellington S, Reeves EL, DeCuir J, McMorrow M, Paden CR, Payne AB, Dawood FS, Surie D; CDC COVID-19 Vaccine Effectiveness Collaborators. Link-Gelles R, et al. Among authors: ong tc. MMWR Morb Mortal Wkly Rep. 2025 Feb 27;74(6):73-82. doi: 10.15585/mmwr.mm7406a1. MMWR Morb Mortal Wkly Rep. 2025. PMID: 40014628 Free PMC article.
Interim Estimates of 2024-2025 Seasonal Influenza Vaccine Effectiveness - Four Vaccine Effectiveness Networks, United States, October 2024-February 2025.
Frutos AM, Cleary S, Reeves EL, Ahmad HM, Price AM, Self WH, Zhu Y, Safdar B, Peltan ID, Gibbs KW, Exline MC, Lauring AS, Ball SW, DeSilva M, Tartof SY, Dascomb K, Irving SA, Klein NP, Dixon BE, Ong TC, Vaughn IA, House SL, Faryar KA, Nowalk MP, Gaglani M, Wernli KJ, Murugan V, Williams OL, Selvarangan R, Weinberg GA, Staat MA, Halasa NB, Sahni LC, Michaels MG, Englund JA, Kirby MK, Surie D, Dawood FS, Clopper BR, Moline HL, Link-Gelles R, Payne AB, Harker E, Wielgosz K, Weber ZA, Yang DH, Lewis NM, DeCuir J, Olson SM, Chung JR, Flannery B, Grohskopf LA, Reed C, Garg S, Ellington S; CDC Influenza Vaccine Effectiveness Collaborators. Frutos AM, et al. Among authors: ong tc. MMWR Morb Mortal Wkly Rep. 2025 Feb 27;74(6):83-90. doi: 10.15585/mmwr.mm7406a2. MMWR Morb Mortal Wkly Rep. 2025. PMID: 40014791 Free PMC article.
Biradical Polarizing Agents at High Fields.
Michaelis VK, Keeler EG, Bahri S, Ong TC, Daviso E, Colvin MT, Griffin RG. Michaelis VK, et al. Among authors: ong tc. J Phys Chem B. 2022 Oct 13;126(40):7847-7856. doi: 10.1021/acs.jpcb.2c03985. Epub 2022 Oct 4. J Phys Chem B. 2022. PMID: 36194539 Free PMC article.
Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia.
Saglio G, Kim DW, Issaragrisil S, le Coutre P, Etienne G, Lobo C, Pasquini R, Clark RE, Hochhaus A, Hughes TP, Gallagher N, Hoenekopp A, Dong M, Haque A, Larson RA, Kantarjian HM; ENESTnd Investigators. Saglio G, et al. N Engl J Med. 2010 Jun 17;362(24):2251-9. doi: 10.1056/NEJMoa0912614. Epub 2010 Jun 5. N Engl J Med. 2010. PMID: 20525993 Free article. Clinical Trial.
Estimated 2023-2024 COVID-19 Vaccine Effectiveness in Adults.
Link-Gelles R, Rowley EAK, Irving SA, Klein NP, Grannis SJ, Ong TC, Ball SW, DeSilva MB, Dascomb K, Naleway AL, Koppolu P, Zerbo O, Fireman B, Hansen J, Timbol J, Block L, Dixon BE, Duszynski TJ, Allen KS, Mayer D, Chavez C, Barron M, Reese SE, Chickery S, Davis JM, Ciesla AA, Mak J, Najdowski M, Akinsete OO, McEvoy CE, Essien IJ, Sheffield T, Bride D, Arndorfer J, Van Otterloo J, Natarajan K, Tenforde MW, DeCuir J, Payne AB. Link-Gelles R, et al. Among authors: ong tc. JAMA Netw Open. 2025 Jun 2;8(6):e2517402. doi: 10.1001/jamanetworkopen.2025.17402. JAMA Netw Open. 2025. PMID: 40560584 Free PMC article.
Effectiveness of 2023-2024 seasonal influenza vaccine against influenza-associated emergency department and urgent care encounters among pregnant and non-pregnant women of reproductive age.
Reeves EL, Dascomb K, Irving SA, Klein NP, Tartof SY, Grannis SJ, Ong TC, Ball SW, Vazquez-Benitez G, Sheffield T, Bride D, Arndorfer J, Van Otterloo J, Naleway AL, Koppolu P, Zerbo O, Jacobson KB, Fireman BH, Hansen JR, Block L, Salas SB, Bezi C, Sy LS, Reyes IAC, Dixon BE, Fadel WF, Rogerson C, Duszynski T, Mayer D, Chavez C, Barron MA, Weber ZA, Yang DH, Cheung A, Payne AB, Link-Gelles R, Adams K, Neelam V, DeSilva MB, Natarajan K, Tenforde MW, DeCuir J, Ellington S, Olson SM. Reeves EL, et al. Among authors: ong tc. Vaccine. 2025 Aug 30;62:127483. doi: 10.1016/j.vaccine.2025.127483. Epub 2025 Jul 13. Vaccine. 2025. PMID: 40660660 Free PMC article.
Effectiveness of BNT162b2 COVID-19 Vaccination in Children and Adolescents.
Klein NP, Demarco M, Fleming-Dutra KE, Stockwell MS, Kharbanda AB, Gaglani M, Rao S, Lewis N, Irving SA, Hartmann E, Natarajan K, Dalton AF, Zerbo O, DeSilva MB, Konatham D, Stenehjem E, Rowley EAK, Ong TC, Grannis SJ, Sloan-Aagard C, Han J, Verani JR, Raiyani C, Dascomb K, Reese SE, Barron MA, Fadel WF, Naleway AL, Nanez J, Dickerson M, Goddard K, Murthy K, Grisel N, Weber ZA, Dixon BE, Patel P, Fireman B, Arndorfer J, Valvi NR, Griggs EP, Hallowell C, Embi PJ, Ball SW, Thompson MG, Tenforde MW, Link-Gelles R. Klein NP, et al. Among authors: ong tc. Pediatrics. 2023 May 1;151(5):e2022060894. doi: 10.1542/peds.2022-060894. Pediatrics. 2023. PMID: 37026401
Developing Record Linkage Methods to Improve Data Quality [Internet].
Ong TC, Voong C, Kwan B, Reno JE, Crume T, Grannis SJ, Hill A, Silvasstar J, Schilling LM, Kahn MG. Ong TC, et al. Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2023 Apr. Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2023 Apr. PMID: 40934357 Free Books & Documents. Review.
138 results